Dual GIP/GLP-1 Receptor Agonist7.5 mg

7.5 mg Tirzepatide Dosage Calculator

Calculate the exact units for your 7.5 mg tirzepatide escalation dose at any vial concentration.

050100

How many units is 7.5 mg of Tirzepatide at 5 mg/mL?

Draw

150units

1.50 mL on a U-100 insulin syringe

7.5 mg ÷ 5 mg/mL × 100 = 150 units

This dose exceeds 50 units (0.5 mL). Volumes greater than 0.5 mL may be uncomfortable for subcutaneous injection. Consult your provider about splitting the dose into two injections.

For educational purposes only. Always follow your provider's instructions.

Quick Reference Table

All dose × concentration combinations

Dose5 mg/mL10 mg/mL15 mg/mL25 mg/mL30 mg/mL60 mg/mL90 mg/mL100 mg/mL
2.5 mg502516.7108.34.22.82.5
5 mg100*5033.32016.78.35.65
7.5 mg150*75*50302512.58.37.5
10 mg200*100*66.7*4033.316.711.110
12.5 mg250*125*83.3*5041.720.813.912.5
15 mg300*150*100*60*502516.715

Values in U-100 insulin syringe units

* Exceeds 50 units (0.5 mL) — may require splitting into two injections

There's an easier way

Tired of calculating doses?

We handle everything — the prescription, the right dose, and shipping straight to your door. No math, no hassle.

Get Started

2-min quiz · Free consultation · No commitment

About the 7.5 mg Dose

The 7.5 mg dose is an escalation step for Mounjaro and Zepbound during weeks 9 through 12. Patients reaching this dose have already completed two months of titration and are moving toward higher therapeutic levels. This mid-range dose often produces noticeable weight loss and appetite suppression improvements compared to the 5 mg step.

Frequently Asked Questions

In a 25 mg/mL vial, 7.5 mg tirzepatide equals 30 units. The calculation is (7.5 / 25) x 100 = 30 units. In a 10 mg/mL vial, it would be 75 units, and in a 30 mg/mL vial, it would be 25 units.

The 7.5 mg dose is the third step in the titration schedule, used during weeks 9 through 12. The full escalation path is: 2.5 mg (weeks 1-4), 5 mg (weeks 5-8), 7.5 mg (weeks 9-12), 10 mg (weeks 13-16), 12.5 mg (weeks 17-20), and 15 mg (weeks 21 onward). Your provider may slow or pause escalation based on your response.

While the standard titration schedule includes 7.5 mg, some providers may adjust the escalation based on patient response and tolerability. However, skipping doses increases the risk of gastrointestinal side effects. The 2.5 mg increments in tirzepatide's schedule are designed to minimize adverse reactions during the dose-escalation phase.

Direct dose comparisons between tirzepatide and semaglutide are not meaningful because they are different molecules with different potencies. However, in clinical trials, mid-range tirzepatide doses like 7.5 mg and 10 mg produced weight loss results comparable to or exceeding semaglutide 2.4 mg, partly due to tirzepatide's dual GIP and GLP-1 receptor activity.

Other Tirzepatide Doses

2.5 mg Tirzepatide5 mg Tirzepatide10 mg Tirzepatide12.5 mg Tirzepatide15 mg Tirzepatide

Related Pages

Tirzepatide CalculatorTirzepatide Dosing

Ready to Get Started?

Take our 2-minute quiz to see if you qualify for GLP-1 treatment.

Start Quiz

Free consultation. No commitment.